Answers are grounded in this paper and cite their sources.
The expansion of NBS is driven by the development of new test modalities and treatment options. In the near future, other techniques such as next-generation sequencing will pave the way for NBS of other IEI. Exciting times await for population-based screening programs.
No takes yet. Share an insight, caveat, or question.
Blom et al. (2023) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: